PLoS ONE,
Год журнала:
2023,
Номер
18(2), С. e0280587 - e0280587
Опубликована: Фев. 15, 2023
Introduction
The
role
of
COVID-19
vaccination
on
the
mental
health
general
population
remains
poorly
understood.
This
study
aims
to
assess
short-term
change
in
depressive
and
anxiety
symptoms
relation
among
Swedish
adults.
Methods
A
prospective
7,925
individuals
recruited
from
ongoing
cohort
studies
at
Karolinska
Institutet,
Stockholm,
Sweden,
or
through
social
media
campaigns,
with
monthly
data
collections
self-reported
December
2020
October
2021
July
2021.
Prevalence
(defined
as
a
total
score
≥10
PHQ-9
GAD-7,
respectively)
was
calculated
one
month
before,
after
first
dose,
and,
if
applicable,
second
dose.
For
not
vaccinated
choosing
report
status
(unvaccinated
individuals),
we
selected
three
measures
GAD-7
2-month
intervals
in-between
based
availability.
Results
5,079
(64.1%)
received
two
doses
vaccine,
1,977
(24.9%)
305
(3.9%)
were
vaccinated,
564
(7.1%)
chose
status.
There
lower
prevalence
compared
unvaccinated
individuals,
especially
Among
receiving
both
(aRR
=
0.82,
95%CI
0.76–0.88
for
depression;
aRR
0.81,
0.73–0.89
anxiety)
0.79,
0.73–0.85
0.73,
0.66–0.81
before
vaccination.
Similar
results
observed
only
dose
0.76,
0.68–0.84
0.72–0.94
anxiety),
comparing
Conclusions
We
improvement
adults
vaccines
current
pandemic.
Our
findings
provide
new
evidence
support
outreach
campaigns
targeting
hesitant
groups.
The Lancet Psychiatry,
Год журнала:
2022,
Номер
9(10), С. 815 - 827
Опубликована: Авг. 17, 2022
COVID-19
is
associated
with
increased
risks
of
neurological
and
psychiatric
sequelae
in
the
weeks
months
thereafter.
How
long
these
remain,
whether
they
affect
children
adults
similarly,
SARS-CoV-2
variants
differ
their
risk
profiles
remains
unclear.In
this
analysis
2-year
retrospective
cohort
studies,
we
extracted
data
from
TriNetX
electronic
health
records
network,
an
international
network
de-identified
health-care
approximately
89
million
patients
collected
hospital,
primary
care,
specialist
providers
(mostly
USA,
but
also
Australia,
UK,
Spain,
Bulgaria,
India,
Malaysia,
Taiwan).
A
any
age
diagnosed
between
Jan
20,
2020,
April
13,
2022,
was
identified
propensity-score
matched
(1:1)
to
a
contemporaneous
other
respiratory
infection.
Matching
done
on
basis
demographic
factors,
factors
for
severe
illness,
vaccination
status.
Analyses
were
stratified
by
group
(age
<18
years
[children],
18-64
[adults],
≥65
[older
adults])
date
diagnosis.
We
assessed
14
diagnoses
after
infection
compared
comparator
cohort.
The
trajectories
represented
time-varying
hazard
ratios
(HRs)
summarised
using
6-month
constant
HRs
(representing
earlier
phase
follow-up,
which
have
not
yet
been
well
characterised
children),
horizon
each
outcome
(ie,
time
at
HR
returns
1),
equal
incidence
two
cohorts.
estimated
how
many
people
died
or
diagnosis
during
follow-up
group.
Finally,
cohorts
directly
before
emergence
alpha
(B.1.1.7),
delta
(B.1.617.2),
omicron
(B.1.1.529)
variants.We
1
487
712
recorded
study
period,
whom
284
437
(185
748
children,
856
588
adults,
242
101
older
adults;
overall
mean
42·5
[SD
21·9];
741
806
[57·8%]
female
542
192
[42·2%]
male)
adequately
number
another
outcomes
whole
differed
substantially.
While
most
had
significantly
greater
than
6
(with
exception
encephalitis;
Guillain-Barré
syndrome;
nerve,
nerve
root,
plexus
disorder;
parkinsonism),
horizons
varied
greatly.
Risks
common
disorders
returned
baseline
1-2
(mood
43
days,
anxiety
58
days)
subsequently
reached
comparison
457
417
days).
By
contrast,
cognitive
deficit
(known
as
brain
fog),
dementia,
psychotic
disorders,
epilepsy
seizures
still
end
period.
Post-COVID-19
adults:
infection,
mood
(HR
1·02
[95%
CI
0·94-1·10)
(1·00
[0·94-1·06])
did
deficit,
insomnia,
intracranial
haemorrhage,
ischaemic
stroke,
(HRs
ranging
1·20
[1·09-1·33]
2·16
[1·46-3·19]).
Unlike
finite
(75
(491
sizeable
proportion
who
received
diagnosis,
either
cohort,
died,
especially
those
dementia
seizures.
Risk
similar
just
versus
variant
(n=47
675
cohort).
Just
(vs
before)
(n=44
835
cohort),
seizures,
observed,
compounded
death
rate.
With
(n=39
845
there
lower
rate
variant,
remained
similar.This
studies
individuals
showed
that
transient,
no
excess
infections.
In
disorder,
persisted
throughout.
differing
suggest
different
pathogenesis
outcomes.
Children
more
benign
profile
do
sustained
higher
some
concern.
fact
waves
indicates
burden
system
might
continue
even
are
less
respects.
Our
findings
relevant
understanding
individual-level
population-level
can
help
inform
our
responses
them.National
Institute
Health
Care
Research
Oxford
Biomedical
Centre,
Wolfson
Foundation,
MQ
Mental
Research.
World Psychiatry,
Год журнала:
2023,
Номер
22(1), С. 4 - 24
Опубликована: Янв. 14, 2023
Psychiatric
genetics
has
made
substantial
progress
in
the
last
decade,
providing
new
insights
into
genetic
etiology
of
psychiatric
disorders,
and
paving
way
for
precision
psychiatry,
which
individual
profiles
may
be
used
to
personalize
risk
assessment
inform
clinical
decision‐making.
Long
recognized
heritable,
recent
evidence
shows
that
disorders
are
influenced
by
thousands
variants
acting
together.
Most
these
commonly
occurring,
meaning
every
a
each
disorder,
from
low
high.
A
series
large‐scale
studies
have
discovered
an
increasing
number
common
rare
robustly
associated
with
major
disorders.
The
most
convincing
biological
interpretation
findings
implicates
altered
synaptic
function
autism
spectrum
disorder
schizophrenia.
However,
mechanistic
understanding
is
still
incomplete.
In
line
their
extensive
epidemiological
overlap,
appear
exist
on
continua
share
large
degree
one
another.
This
provides
further
support
notion
current
diagnoses
do
not
represent
distinct
pathogenic
entities,
ongoing
attempts
reconceptualize
nosology.
also
influences
range
behavioral
somatic
traits
diseases,
including
brain
structures,
cognitive
function,
immunological
phenotypes
cardiovascular
disease,
suggesting
shared
potential
importance.
Current
polygenic
score
tools,
predict
susceptibility
illness,
yet
provide
clinically
actionable
information.
likely
improve
coming
years,
they
eventually
become
part
practice,
stressing
need
educate
clinicians
patients
about
use
misuse.
review
discusses
key
possible
applications,
suggests
future
directions.
Frontiers in Pharmacology,
Год журнала:
2022,
Номер
13
Опубликована: Апрель 29, 2022
Oxidative
stress
is
a
pivotal
point
in
the
pathophysiology
of
COVID-19
and
presumably
also
Long-COVID.
Inflammation
oxidative
are
mutually
reinforcing
each
other,
thus
contributing
to
systemic
hyperinflammatory
state
coagulopathy
which
cardinal
pathological
mechanisms
severe
stages.
patients,
like
other
critically
ill
patients
e.g.
with
pneumonia,
very
often
show
deficiency
antioxidant
vitamin
C.
So
far,
it
has
not
been
investigated
how
long
this
lasts
or
whether
COVID
symptoms
suffer
from
deficiencies.
A
C
deficit
serious
consequences
because
one
most
effective
antioxidants,
but
co-factor
many
enzymatic
processes
that
affect
immune
nervous
system,
blood
circulation
energy
metabolism.
Because
its
anti-oxidative,
anti-inflammatory,
endothelial-restoring,
immunomodulatory
effects
supportive
intravenous
(iv)
use
supraphysiological
doses
so
far
12
controlled
observational
studies
altogether
1578
inpatients
COVID-19.
In
these
an
improved
oxygenation,
decrease
inflammatory
markers
faster
recovery
were
observed.
addition,
early
treatment
iv
high
dose
seems
reduce
risks
courses
disease
such
as
pneumonia
mortality.
Persistent
inflammation,
thrombosis
dysregulated
response
(auto-immune
phenomena
and/or
persistent
viral
load)
seem
be
major
contributors
inflammation
involved
development
progression
fatigue
neuro-psychiatric
various
diseases
by
disrupting
tissue
(e.g.
autoantibodies),
flow
thrombosis)
neurotransmitter
metabolism
excitotoxicity).
oncological
diseases,
infections
autoimmune
associated
fatigue,
cognitive
disorders,
pain
depression
similar
Long-COVID,
was
shown
significantly
relieve
symptoms.
Supportive
acute
might
therefore
risk
International Journal of Environmental Research and Public Health,
Год журнала:
2022,
Номер
19(11), С. 6865 - 6865
Опубликована: Июнь 3, 2022
We
aimed
to
review
the
data
available
evaluate
long-term
consequences
of
coronavirus
disease
2019
(COVID-19)
at
6
months
and
above.
searched
relevant
observational
cohort
studies
up
9
February
2022
in
Pubmed,
Embase,
Web
Science.
Random-effects
inverse-variance
models
were
used
Pooled
Prevalence
(PP)
its
95%
confidence
interval
(CI)
consequences.
The
Newcastle–Ottawa
quality
assessment
scale
was
assess
included
studies.
A
total
40
involving
10,945
cases
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
infection
included.
Of
patients,
63.87%
had
least
one
consequence
month
follow-up,
which
decreased
58.89%
12
months.
most
common
symptoms
fatigue
or
muscle
weakness
(PP
6–12
m
=
54.21%,
PP
≥
34.22%)
mild
dyspnea
(Modified
Medical
Research
Council
Dyspnea
Scale,
mMRC
0,
74.60%,
80.64%).
Abnormal
computerized
tomography
(CT;
55.68%,
43.76%)
lung
diffuse
function
impairment,
i.e.,
a
carbon
monoxide
diffusing
capacity
(DLCO)
<
80%
49.10%,
31.80%).
Anxiety
depression
33.49%,
35.40%)
pain
discomfort
33.26%,
35.31%)
problems
that
affected
patients’
life.
Our
findings
suggest
significant
impact
on
health
life
due
COVID-19,
as
waves
ASRS-CoV-2
infections
emerge,
effects
COVID-19
will
not
only
increase
difficulty
care
for
survivors
setting
public
policy
but
also
might
lead
another
crisis
following
current
pandemic,
would
global
burden
disease.
International Journal of Environmental Research and Public Health,
Год журнала:
2023,
Номер
20(3), С. 2362 - 2362
Опубликована: Янв. 29, 2023
The
COVID-19
pandemic
has
resulted
in
negative
mental
health
outcomes
throughout
the
world,
and
its
impact
on
social
interactions
relationships
is
likely
to
be
evident
problematic
anxiety.
This
systematic
review
qualitatively
synthesized
data
from
studies
that
have
reported
effects
of
A
search
Web
Science
Core
Collection,
Embase,
PsychINFO,
Scopus,
EBSCOhost,
Cochrane
Central
Register
Controlled
Trials,
Proquest
Central—Dissertations
Theses
was
conducted,
with
thirty-three
meeting
inclusion
criteria.
results
suggest
anxiety
been
heightened
general
population
due
pandemic,
women
low-income
earners
being
especially
vulnerable.
Other
contributing
factors
include
impaired
coping
strategies,
lower
socio-emotional
well-being,
limited
support
networks,
contraction
SARS-CoV-2
virus.
Individuals
a
Social
Anxiety
Disorder
diagnosis
may
at
risk
deterioration
general.
Limitations
literature
reviewed
predominance
cross-sectional
study
designs,
which
limit
causal
inferences
are
limited.
Additionally,
associations
inflated
as
many
not
accounted
for
mediating
variables.
Taken
together,
research
suggests
anxiety,
either
pre-pandemic
or
arising
environment,
contributed
variety
related
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Ноя. 1, 2023
Abstract
There
have
been
hundreds
of
millions
cases
coronavirus
disease
2019
(COVID-19),
which
is
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
With
the
growing
population
recovered
patients,
it
crucial
to
understand
long-term
consequences
and
management
strategies.
Although
COVID-19
was
initially
considered
an
illness,
recent
evidence
suggests
that
manifestations
including
but
not
limited
those
cardiovascular,
respiratory,
neuropsychiatric,
gastrointestinal,
reproductive,
musculoskeletal
systems
may
persist
long
after
phase.
These
persistent
manifestations,
also
referred
as
COVID,
could
impact
all
patients
with
across
full
spectrum
illness
severity.
Herein,
we
comprehensively
review
current
literature
on
highlighting
its
epidemiological
understanding,
vaccinations,
organ-specific
sequelae,
pathophysiological
mechanisms,
multidisciplinary
In
addition,
psychological
psychosomatic
factors
underscored.
Despite
these
findings
diagnostic
therapeutic
strategies
based
previous
experience
pilot
studies
remain
inadequate,
well-designed
clinical
trials
should
be
prioritized
validate
existing
hypotheses.
Thus,
propose
primary
challenges
concerning
biological
knowledge
gaps
efficient
remedies
well
discuss
corresponding
recommendations.
Post
COVID-19
syndrome,
also
known
as
"Long
COVID,"
is
a
complex
and
multifaceted
condition
that
affects
individuals
who
have
recovered
from
SARS-CoV-2
infection.
This
systematic
review
meta-analysis
aim
to
comprehensively
assess
the
global
prevalence
of
depression,
anxiety,
sleep
disorder
in
coping
with
syndrome.